Mental Health Clinics in Topton, PA Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Diakon Family Life Services Northeast Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1 S Home Ave, Topton, PA 19562 Phone: 717-795-0330 |
Diakon Family Life Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1 S Home Ave, Topton, PA 19562 Phone: 610-682-1242 |
Concern-professional Services For Children, Youth & Families Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 445 W Barkley St, Topton, PA 19562 Phone: 610-682-5171 |
Concern-professional Services For Children, Youth & Families Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 200 W Weis St, Topton, PA 19562 Phone: 610-682-5156 |
News Archive
Quintiles, SNUH announce clinical research partnership
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today celebrated its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program. SNUH is Quintiles' second Prime Site in Asia, adding to six other existing sites located in the United States, Europe and Africa.
Researchers decipher genetic material of 48 pediatric glioblastomas
Glioblastomas grow extremely aggressively into healthy brain tissue and, moreover, are highly resistant to radiation therapy and chemotherapy. Therefore, they are regarded as the most malignant type of brain tumor. Currently available treatment methods are frequently not very effective against this type of cancer. Glioblastoma can affect people of all ages, but is less common in children than in adults.
Researchers discover protein that may help predict breast cancer prognosis
Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published ahead of print in the journal Molecular and Cellular Biology.
IND for Cytopia's CYT387 clears the FDA review
Cytopia Limited's Investigational New Drug Application (IND) for CYT387 has passed US Food and Drug Administration (FDA) review. CYT387 is a small-molecule oral JAK1/JAK2 kinase inhibitor designed to treat various haematological disorders.
Tired B cells hamper immune response to HIV
Recent studies have shown that HIV causes a vigorous and prolonged immune response that eventually leads to the exhaustion of key immune system cells-CD4+ and CD8+ T-cells-that target HIV.
› Verified 1 days ago